FDA issues lamotrigine (Lamictal®) warning

On April 25, 2018, the U.S. Food and Drug Administration (FDA) issued a warning that the medicine lamotrigine (Lamictal) can cause a rare but very serious reaction known as hemophagocytic lymphohistiocytosis (HLH).

Notification_close

Cardiology Imaging Program

Horizon Blue Cross Blue Shield of New Jersey has partnered with eviCore healthcare to administer our Cardiology Imaging program by using evidence-based criteria and ensuring requests for advanced cardiac imaging meet quality standards recommended by organizations such as the American College of Cardiology, the American Heart Association and the Heart Rhythm Society and identifying the most appropriate cardiac imaging study based on the patient’s medical and prior imaging history.

Cardiology Q&A
Diagnostic Radiology/Imaging Equipment Standards
CPT codes requiring PA/MND and billing information
Archive